Aspirin-induced asthma: A tribute to John Vane as a source of inspiration

Pharmacological Reports

Volumn 62, Issue 3, 2010, Pages 526-529

  Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aspirin; Asthma; Cyclooxygenase; Leukotrienes; Prostanoids

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; CYCLOOXYGENASE 1; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANAPHYLAXIS; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BRONCHOSPASM; BRONCHUS OBSTRUCTION; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG RECHALLENGE; ENZYME INHIBITION; EPIPHORA; HUMAN; ICOSANOID METABOLISM; NASAL PRURITUS; NOSE CONGESTION; ORBIT TUMOR; PATHOPHYSIOLOGY; RASH; REVIEW; RHINITIS; RHINORRHEA; SEX RATIO; SIDE EFFECT; SNEEZING; CHEMICALLY INDUCED; METABOLISM; RESPIRATORY TRACT ALLERGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; HUMANS; RESPIRATORY HYPERSENSITIVITY;

EID: 77954857757     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70309-1     Document Type: Review

References (13)

1. Berges-Gimeno M, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol, 2002, 89, 474-478.
2. Bujalska M, Makulska-Nowak H: Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine and streptozotocin-induced hyperalgesia. Pharmacol Rep, 2009, 61, 631-640.
3. Gryglewski RJ: Prostacyclin among prostanoids. Pharmacol Rep, 2008, 60, 3-11.
4. Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin-induced asthma and its implications for clinical practice. BMJ, 2004, 328, 434-437.
5. Settipane GA: Landmark commentary: history of aspirin intolerance. Allergy Proc, 1990, 11, 251-252.
6. Szczeklik A: Aspirin-induced asthma as a viral disease. Clin. Allergy, 1988, 18, 15-20.
7. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J, 1975, 1, 67-69.
8. Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J, 2000, 16, 432-436.
9. Szczeklik A, Nizankowska E, Mastalerz L, Bochenek G: Myocardial ischemia possibly mediated by cysteinyl leukotrienes. J Allergy Clin Immunol, 2002, 109, 572-573.
10. Szczeklik A, Nizankowska-Mogilnicka E, Sanak M: Hypersensitivity to Aspirin and Nonsteroidal Anti-Inflammatory Drugs. In: Middleton's Allergy, 7th edn., Eds. Adkinson NF, Busse WW, Bochner BS, Holgate ST, Simons FGR, Lemanske RF, Mosby Elsevier, Philadelphia, PA, 2009, 1227-1243.
11. Szczeklik A, NiZankowska-Mogilnicka E, Sanak M: Hypersensitivity to aspirin and other NSAIDs. In: Allergy and Allergic Diseases. 2nd edn., Eds. Kay AB, Kaplan AP, Bousquet J, Holt PG, Wiley-Blackwell, New York, 2008, 1966-1979.
12. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature, 1971, 231, 232-234.
13. Wos M, Sanak M, Soja J, Olechnowicz H, Busse WW, Szczeklik A: Persistence of rhinovirus infection in lower airways of patients with bronchial asthma. Am J Respir Crit Care Med, 2008, 177, 1082-1089.